HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, HopeAI presented new results demonstrating how AI-generated synthetic individual patient data ( SynthIPD ) can accelerate regulatory-grade evidence generation — without the need for real patient-level…
Apriori to leverage foundational insights from the Crick’s Legacy Study to further validate Octavia platform’s ability to predict viral evolution and vaccine performance Apriori Bio, a biotechnology company focused on developing variant-resilient vaccines, today announced a research collaboration with the Francis Crick Institute to better understand critical aspects of immune response, with the goal of informing…
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings. To develop novel treatments for patients, scientists must first understand the biological…
In direct support of the White House and CMS’s bold initiative to “Make Health Tech Great Again,” Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology. With its Patient Connect app and intelligent assistant DrArturoAI already live and serving patients,…
– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using the Everads Injector to repair retinal detachments – Everads Therapy, a clinical-stage company leveraging its novel suprachoroidal delivery technology to advance the treatment of retinal diseases, today announced two oral presentations…
Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovation Unlearn®, a leader in AI solutions for clinical trials, today announced the appointment of Kwame Marfo as its Vice President of Product. Marfo’s appointment solidified Unlearn’s trajectory, as it continues to scale and advance its…
Anervea to Build Breakthrough ClinDev Optimization Suite on Komodo’s MapLab Enterprise, Harnessing Real-World Data and AI to Accelerate Market Access and Improve Patient Outcomes Komodo Health, the Evidentiary Standard for real-world patient-journey insights and healthcare analytics, today announced a strategic partnership with Anervea.ai, an AI-native Life Sciences technology company, to accelerate innovation across Clinical Development….
Anervea to Build Breakthrough ClinDev Optimization Suite on Komodo’s MapLab Enterprise, Harnessing Real-World Data and AI to Accelerate Market Access and Improve Patient Outcomes Komodo Health, the Evidentiary Standard for real-world patient-journey insights and healthcare analytics, today announced a strategic partnership with Anervea.ai, an AI-native Life Sciences technology company, to accelerate innovation across Clinical Development….
Powering Alzheimer’s research with AI-driven insights across cognition, meaning, motor function, and speech — accelerating study recruitment and enabling more equitable, personalized brain health care Linus Health, which is revolutionizing brain health with science-driven digital solutions, will present two oral presentations and eight posters at the Alzheimer’s Association International Conference® (AAIC®) 2025, taking place July 27-31 in Toronto and virtually. Linus Health…
Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health, Pennington Biomedical Research Center, and Tulane University — a tech-bio innovator…